Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Tipo de estudio
Intervalo de año de publicación
1.
Arch Razi Inst ; 77(5): 1723-1728, 2022 10.
Artículo en Inglés | MEDLINE | ID: mdl-37123152

RESUMEN

Pseudomonas aeruginosa (P. aeruginosa) is a ubiquitous opportunistic organism that is hard to treat. This study aimed to investigate the association of bla VIM, bla IMP, and bla NDM prevalence with Cyclic di-GMP (c-di-GMP) in P. aeruginosa. To this end, 27 clinical isolates of P. aeruginosa were obtained from different hospitals in Baghdad, Iraq. The phenotypic detection of carbapenem and biofilm assays was performed by the M63 minimal medium, supplemented with glucose, magnesium sulfate. The polymerase chain reaction was utilized to detect carbapenem genes. The results showed that the isolates were highly resistant to Imipenem (37%) and Meropenem (63%). Imipenem (37%) and Meropenem (63%) demonstrated a moderate sensitivity against P. aeruginosa. The P. aeruginosa No.5 showed high resistance to carbapenem by bla VIM +, bla IMP +, and bla NDM +, followed by a robust biofilm confirmed with c-di-GMP levels and the twitching motility ability. Upon these findings, the use of antibiotics should be restricted to severe bacterial infections to avoid the rapid emergence of new resistant isolates, which leads to the hard treatment of infection with P. aeruginosa. It is highly recommended that these findings be notified for infectious control. Future studies can investigate the link between transferable resistant genes and c-di-GMP values.


Asunto(s)
Proteínas Bacterianas , Pseudomonas aeruginosa , Proteínas Bacterianas/genética , beta-Lactamasas/genética , Carbapenémicos , Imipenem , Meropenem , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/genética , Biopelículas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...